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Background: Intense pain can last several days after tonsillectomy. It is often undertreated and improved analgesic
strategies that can be safely used at home are needed.
Methods: We conducted a systematic review and meta-analysis on the effectiveness of systemic medications used for
post-tonsillectomy pain in adult and adolescent (13 yr old) patients. Studies were identified from PubMed, the Cochrane
Library, and by hand searching reference lists from studies and review articles. Randomised, double-blind, placebo-
controlled studies reporting on pain intensity or use of rescue analgesia were included.
Results: Twenty-nine randomised controlled trials representing 1816 subjects met the inclusion criteria. Follow-up time
was 24 h in 15 studies, in which the majority were taking nonsteroidal anti-inflammatory drugs. Thirteen studies were
suitable for meta-analysis. In pooled analysis, paracetamol, dexamethasone, and gabapentinoids reduced pain intensity
on the day of operation. In individual studies, ketoprofen, ibuprofen, lornoxicam, parecoxib, rofecoxib, indomethacin and
dextromethorphan reduced pain intensity, need for rescue analgesics, or both on the day of operation. Oral celecoxib for
2 postoperative weeks or i.v. ketamine on the day of operation were not effective at the studied doses. Dexamethasone in
multiple doses provided analgesia beyond 1 postoperative day. Pain was moderate to strong in both study and control
groups during the first postoperative week.
Conclusions: Single analgesics and dexamethasone provide only a weak to moderate effect for post-tonsillectomy pain
on the day of operation and thus a multimodal analgesic strategy is recommended. Short follow-up times and clinical
heterogeneity of studies limit the usefulness of results.
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 The authors performed a systematic review and meta-
analysis of pain management after tonsillectomy.
Data were scarce and postoperative follow-up was
short in the majority of studies.
 Paracetamol, NSAIDs, dexamethasone, gabapentinoids,
and dextromethorphan showed weak to moderate
analgesic effects on the day of operation.
 The authors suggest that multimodal analgesia is
needed after tonsillectomy, and that further research
on post-tonsillectomy pain is required, with follow-up
over at least 1 week.
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e398 - Tolska et al.Tonsillectomy is one of the most common procedures in
ear, nose, and throat surgery. It is usually performed as a day-
stay procedure.1 Pain is the most common reason for physi-
cian contact after discharge, indicating that post-
tonsillectomy pain is intense and undertreated.2 Patients
need analgesics that are effective and can be used safely at
home.
Adults have a different pattern of pain compared with
children; this is related to the different indications and tech-
niques of tonsillectomy.3,4 In adults, the surgery is usually
performed for chronic infection with scarred tonsils that re-
quires dissection with coagulation, thus causing intense and
longer-lasting pain.5 In children, the indication is usually hy-
pertrophy or recurrent acute infections with smaller changes
in tonsil tissues than in adults.6
Multimodal analgesia has become the standard of care in
postoperative pain management. Combinations of analgesics
with different sites or modes of action are commonly used to
improve analgesia and to reduce the doses of individual an-
algesics (especially opioids) and to reduce adverse effects.
Adverse effects of opioids, such as sedation and respiratory
depression, are particularly dangerous when the surgery has
been performed along the respiratory tract. The benefits of
analgesics and dexamethasone used for post-tonsillectomy
pain require review. Systematic reviews on various analge-
sics for post-tonsillectomy pain have been published for pae-
diatric and adolescent patients.7 Paracetamol (alone and in
combination with ibuprofen) for acute postoperative pain has
been analysed in systematic reviews that have included some
tonsillectomy studies.8e10 Also, the effects of NSAIDs on the
risk for post-tonsillectomy haemorrhage (PTH) have been
studied widely.11e13 Reviews on the effect of dexamethasone
on post-tonsillectomy morbidity have mainly focused on the
risk for PTH and postoperative nausea and vomiting (PONV);
we found one review that included pain as a clinical endpoint
in adults.14 Additionally, one study reviewed the effect of
dexamethasone for post-tonsillectomy pain only.15 Reviews
on gabapentinoids for acute pain after general surgery, post-
tonsillectomy, and after head-neck surgery have been pub-
lished.16e18 However, the effect of various analgesics on post-
tonsillectomy pain in adults has not been systemically
reviewed, to our knowledge.
We performed a systematic review and meta-analysis of
published studies to assess the effect of systemic analgesics in
the treatment of post-tonsillectomy pain in adult and
adolescent patients. Randomised, double-blind, placebo-
controlled studies reporting at least one analgesic outcome
(such as incidence or intensity of pain) or use of rescue anal-
gesics were included.Methods
The Preferred Reporting Items for Systematic Reviews and
Meta-Analyses (PRISMA) statement guidelines were followed
in performing and reporting the review.19
Search strategy
The following electronic databases were searched to iden-
tify published or ongoing RCTs: Pubmed, Ovid MEDLINE,
The Cochrane Central Register of Controlled Trials (CEN-
TRAL), and Cochrane Database of Systematic Reviews
(CDSR). We used the following search terms: (tonsillectomy
or tonsillectomy* or tonsillotomy or post tonsillectomy)AND (pain or pain* or analgesia or analgesic* or narcotics).
The search retrieved only a few studies on dexamethasone.
Therefore, targeted searches were made using the following
terms: (tonsillectomy or tonsillectomy* or tonsillotomy or
post tonsillectomy) AND (dexamethasone* or corticoste-
roids*). We searched trial registries www.clinicaltrials.gov
and www.eudraCT.com for unpublished trials. We hand-
searched reference lists of included studies and identified
reviews for additional potential trials. The search was per-
formed in February 2017 and conducted by one author (KT).
Three reviewers (KT, AT, KH) independently screened all
studies for eligibility by titles and abstracts, and a decision
was made on whether to obtain full-text publications.
These studies were then inspected for relevance and a de-
cision was made on whether to include or exclude them.
Disagreements between reviewers were resolved by
consensus.Inclusion criteria
Types of studies: double-blind placebo-controlled randomised
studies (RCTs) of systemic analgesics for post-tonsillectomy
pain in adults or adolescents. Only publications in English
were included.20 Studies published before 1980 were excluded,
as operation techniques have evolved and hence the study
settings would not be comparable with those in more recent
years.
Types of participants: adults and adolescents (13 yr old)
undergoing tonsillectomy for any indication as inpatient or
outpatient. Studies on paediatric patients andmixed studies of
adult and paediatric patients were excluded. Studies of less
than 10 participants in a group were excluded.
Types of intervention: administration of systemic (oral,
rectal, i.m., or i.v.) analgesics (paracetamol, NSAIDs, gaba-
pentin, pregabalin, dextromethorphan, ketamine) and dexa-
methasone for prevention or treatment of pain. Studies on
topical, infiltration, and regional analgesics were excluded.
Types of outcome measures: the primary outcome was
incidence or intensity of pain, or both; secondary outcomes
were the use of rescue analgesia and adverse effects. Studies
that did not report at least one analgesic outcome measure
were excluded.Data collection
We developed a data abstraction table, pilot-tested it on five
randomly selected studies, and refined it accordingly. Data
collection from included studies was performed by one author
(KT) and reviewed by two other authors (AT, KH). Disagree-
ments were resolved by discussion between three authors
(HKT, AT, KH). A fourth author (VKK) was consulted if no
agreement was reached.
The following data on study participants were extracted:
age, number of patients, ASA status (ASA Physical Status
Classification System), number and reason for dropouts,
type and technique of operation, type of anaesthesia (local
or general, whether analgesics were used during anaes-
thesia), type of intervention (type, dose, frequency, and
timing of analgesics [preoperative, intraoperative, or post-
operative]), additional and rescue analgesics, method of pain
measurement and by whom (patient or observer), type of
comparator (placebo), type of outcome measure (pain in-
tensity before and after medication, rescue analgesics,
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up, and study design (randomisation, blinding of random-
isation, and intervention).Quality assessment and risk of bias in and across
individual studies
Three authors (HKT, KH, AT) independently assessed the val-
idity and potential bias of included studies by evaluating the
adequacy of randomisation and concealment of allocation
(sequence generation), blinding of patients, healthcare pro-
viders, data collectors, and outcome assessors, intention-to-
treat, and for incomplete outcome data and selective
outcome reporting. The Cochrane risk of bias tool was used for
assessment of methodological quality of included studies.21
Publication bias of included studies was determined by a
funnel plot.Statistical analysis and synthesis
Data were analysed by calculating the mean difference with
the corresponding 95% confidence intervals (CI). We per-
formed meta-analyses of included studies when a group of
studies in which clinical heterogeneity was sufficiently small
could be identified. Data were analysed using Review Manager
(RevMan; version 5.3; Copenhagen: The Nordic Cochrane
Centre, The Cochrane Collaboration, 2014). Statistical hetero-
geneity was analysed with a c2 test and I2 was calculated.
Pooled meta-analyses were not performed in case clinical
heterogeneity was too great or reporting of outcomemeasures
varied excessively within a group of analgesics. Instead,
narrative synthesis was used to compare studies qualitatively
by using significant differences reported in original studies. In
the overall interpretation of the results, we consider that ‘no
more than mild pain’ (less than 3/10 in the pain scale) is an
acceptable result in clinical practice (moderate pain 3e6/10,
strong/severe pain 6e10/10).22Results
We retrieved 2219 citations from an electronic database search
and an additional 14 citations from reference lists of reviews
(Fig. 1). After excluding duplicates and articles that did not
fulfil the inclusion criteria, full-text articles of 81 studies were
assessed for eligibility, based on the title and abstract. Of
these, 29 studies representing 1816 patients met the inclusion
criteria, of which 13 were suitable for pooled meta-analysis.Characteristics of the included studies
The main characteristics and results of the included studies
are shown in Table 1. A detailed description is shown in
Supplementary Appendix S1. Two studies investigated para-
cetamol,23,24 nine NSAIDs,25e33 10 dexamethasone,34e43 three
gabapentin,44e46 one pregabalin,47 two dextromethorphan,48,49
one ketamine,50 and one oxycodone.51 Patients undergoing
adenotonsillectomy were included in two studies.28,33 In the
remaining studies, all patients underwent tonsillectomy. Sur-
gerywas performed under general anaesthesia in 27 studies; in
two studies the type of anaesthesia was not reported.25,41 The
surgical method was described in 19 studies.
Patients in one study received dexamethasone in addition
to study medication.33 Additional preoperative or post-
operative analgesics were given in 13 studies, no additionalanalgesics were given in 10 studies, and information was not
provided in six studies (Table 1). Rescue analgesics were given
in 25 studies, were not allowed in one study,37 and information
was not provided in three studies.34,43,51
Study medications were administered before operation in
eight studies,29e31,45e49 before operation and intraoperatively
in one study,44 intraoperatively in seven studies,8,26,34,35,38,43,50
intraoperatively and after operation in five studies,27,32,36,37,39
after operation in seven studies,23e25,33,40,41,51 and before and
after operation in one study.44 One study compared intra-
operative and postoperative administration of the study
medication with placebo.28 Another study compared preop-
erative, intraoperative, and postoperative administration of
the study medication with placebo.42 There were 17 single-
dose and 12 multiple-dose studies. In studies that compared
more than one analgesic with placebo, only one study armwas
analysed. The duration of follow-up times ranged from 70min
to 10 days (Table 2). If 4-h or 24-h data were not available, we
used the datapoint closest to time. There were three multi-
centre studies.32,39,44
Pain intensity was the primary outcome in 11 stud-
ies29e33,35,36,38,39,44,47 and rescue analgesia in six studies
(number of doses during follow-up,23 proportion of patients
requiring rescue analgesics to maintain visual analogue scale
[VAS] at rest [VASr] 30 mm and VAS on swallowing (VASs)
50 mm,24 total dose of rescue analgesics,27,50 proportion of
patients that needed rescue analgesics,28 and time to first
analgesic request after discharge from operating room49).
Twelve studies did not specify the primary outcome but re-
ported data on pain intensity,34,37,40e43,45,46,48,51 pain relief,25
and rescue analgesia.26 We converted pain intensity values
to a 0e10 scale when a 0e5 scale was used in a study. Pain
intensity scales of 0e6 and 0e4 were used in one dexa-
methasone study42 and in one gabapentin study,44 respec-
tively; in these studies, we considered that converting values
to 0e10 scales would not be appropriate, and they were
excluded from pain intensity comparisons in meta-analyses.
Pain intensity was reported in all but one study26 in which
the only need for rescue analgesics was evaluated (total
number of doses and time to first rescue analgesic). Pain in-
tensity was reported by the patient in 11 studies and by an
observer in 10 studies. Seven studies did not report who
assessed pain intensity. The criteria for administration of
rescue analgesia were reported in 24 studies, of which 10
studies reported a specified pain intensity value for adminis-
tration of rescue analgesia.Quality and risk of bias of included studies
All included studies were randomised, double-blind, and pla-
cebo controlled. The risk of bias graph is presented in Fig. 2 and
the risk of bias summary in Supplementary Appendix S2.
Detailed characteristics of bias in included studies are pre-
sented in Supplementary Appendix S3.Pain intensity after tonsillectomy
Tonsillectomy caused moderate to severe pain that lasted for
several days (Fig. 3). During the first postoperative week, pain
intensities (median or mean as shown in figures) in both pla-
cebo and study groups ranged from 4 to 8 (pain intensity scale
0e10). By the end of the first postoperative week (7 POD), pain
intensity had decreased to less than 4/10 in the majority of
study groups, whereas in the majority of placebo groups, pain
Records of studies idenﬁed 
through database searching
(n=2219)
Addional abstracts idenﬁed through other sources (trial 
registries, reference lists)
(n=14)
Records of studies aer duplicates removed
(n=1228)
Abstracts screened
(n=1242)
Abstracts excluded
(n=1161)
Full-text arcles assessed for eligibility
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Full-text arcles excluded, 
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(n=52)
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Not RCT: 6
No placebo: 21
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Fig 1. Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) flow diagram.
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respectively).Randomised studies comparing paracetamol with
placebo
Two studies involving 153 participants23,24 are summarised in
Table 1 (Supplementary Appendix S1). The pooled estimate for
intraoperatively administered paracetamol 1e2 g i.v. showed a
statistically significant decrease in pain intensity (VASs) at 4 h
(0.88 [95% CI 1.66 to 0.09], P¼0.03), equivalent to an 18%
reduction compared with the control group. Both studies
(single dose of 2 g i.v. intraoperatively24 and multiple doses up
to 4 g i.v. on the day of operation23) reported a decreased need
for opioids within 24 h. One study24 that reported incidence ofPTH found no association between paracetamol and increased
risk for PTH.Randomised studies comparing NSAIDs with placebo
Nine studies involving 638 participants25e33 are summarised
in Table 1 (Supplementary Appendix S1). Only two studies27,28
reported pain intensity values as mean with standard devia-
tion (SD) or standard error of mean (SEM was converted to SD)
for which a pooled meta-analysis was possible. Intraoperative
ketoprofen failed to decrease pain intensity at 2 h and at 24 h
(VASs scale 0e10) (0.82 [95% CI 2.10 to 0.45], P¼0.21
and 0.67 [95% CI 1.53 to 0.19], P¼0.13, respectively) (Fig. 4).
Both studies reported a reduced need for rescue analgesics
within 24 h.
Table 1Main characteristics and results of the included studies. intraop., intraoperatively; max, maximal; n, number; No., number; NS, not significant; POD, postoperative day; postop.,
after operation; preop., before operation; SD, standard deviation; sEMG, surface electromyography; TCI, target controlled infusion; VAS, visual analogue scale; VASr, VAS at rest; VASs,
VAS on swallowing; VRS, verbal rating scale
Reference (and
year)
No. of patients,
active/placebo
Study analgesics
Study arm
Placebo
Time of administration
Rescue analgesic, time of
administration
Duration of
follow-up
(days)
Analgesic outcome results (study drug vs placebo)
Atef and
Fawaz23 (2008)
38/38 Paracetamol 1 g i.v. saline i.v.
Intraop., 6, 12, 18 h
Pethidine 1 mg kg1 i.m. if
VASr>30, 0e24 h
1 Paracetamol reduced total dose of i.m. pethidine during 0e24 h
(P<0.001), n of pethidine doses/patient 0e24 h (P<0.001) and %
of patients that needed pethidine (P<0.05)
Paracetamol decreased VASs and VASr at 2 and 3 h (P<0.05)
Salonen and
colleagues24
(2009)
39/37/38 Paracetamol 2 g i.v.
Paracetamol 1 g i.v.
Saline i.v.
10 min postop.
Oxycodone 2 mg i.v. if
VASr>30 or VASs>50, 0
e6 h
6 Proportion of patients that needed oxycodone 0e6 h NS
Paracetamol 2 g reduced n of oxycodone doses/patient 0e6 h
(P¼0.002), paracetamol 1 g NS. Time to 1st dose of oxycodone
NS. Pain intensity NS
Parker and
colleagues25
(1986)
44/33/33 Ibuprofen 600 mg p.o.
Acetylsalicylic acid 600 mg p.o.
30 ml syrup p.o.
0e4 times daily for 0e6 postop.
days as needed
Analgesia p.o. or i.m., dose
or type unclear, hospital
Paracetamol, home
6 Ibuprofen provided pain relief at 30 min (% of patients with pain
50% gone) (P<0.05), at 4 h ibuprofen and acetylsalicylic acid NS
Analgesic consumption: ibuprofen and acetylsalicylic acid 3e4
daily, placebo less, no numerical data. Rescue analgesia: no
one requested
Rorarius and
colleagues26
(1993)
21/21/21 Indomethacin 50 mg i.v.
Diclofenac 75 mg i.v.
Saline i.v.
Intraop.
Oxycodone 3 mg i.v., 0e70
min
<1 Indometacin reduced n of oxycodone doses/group (P¼0.05).
Time to 1st rescue analgesic NS. Proportion of patients that
needed oxycodone NS
Tarkkila and
Saarnivaara27
(1999)
20/20/20/20 Ketoprofen 100 mg i.v.
Diclofenac 75 mg i.v.
Ketorolac 30 mg i.v.
Saline i.v.
Intraop., 6, 12 h
Oxycodone 0.05 mg kg1
i.v., 0e2 h
Oxycodone 0.1 mg kg1
i.m., 2e24 h
1 All NSAIDs reduced total n of oxycodone doses/patient 0e24 h
(P<0.05)
Ketorolac reduced proportion of patients that requested
oxycodone (P<0.05). Pain intensity NS
Salonen and
colleagues28
(2001)
41/40/25 Ketoprofen 0.5 mg kg1 i.v. bolus
with ketoprofen infusion 3 mg
kg1
Saline i.v. bolus with infusion
Bolus at induction (‘intra’) or in
PACU (‘post’) with 24 h infusion
in both
Oxycodone 0.05 mg kg1
i.v. if VASr30, 0e4 h
Oxycodone 0.1 mg kg1
i.m. if VASr30, 4e24 h
1 Proportion of patients that needed oxycodone in PACU 0e4 h NS,
intra- and post-ketoprofen at ward 5e24 h reduced (P¼0.002), 0
e24 h NS
Intra- and post-ketoprofen reduced n of oxycodone doses/
patient at all time intervals vs placebo: 0e4 h (P¼0.03, P¼0.04,
respectively), 5e24 h (P<0.01, P<0.01, respectively) and 0e24 h
(P<0.01, P<0.01 respectively). Total dose of oxycodone NS
Naesh and
colleagues29
(2005)
20/20 Rofecoxib 50 mg p.o. identical
capsules p.o.
1.5 h preop.
Morphine 2.5 mg i.v. until
VAS<3 or patient
comfortable, 0e24 h
1 VAS 0e24 h NS. Rofecoxib reduced strong pain (VAS>5) 0e8 h:
(P¼0.02)
Rofecoxib reduced total dose of morphine during 0e8 h
(P<0.04)
Time to 1st rescue dose NS
Ismail and
Mowafi30
(2010)
20/19 Lornoxicam 16 mg i.v.
Saline i.v.
30 min before induction
Solpadeine plus
(paracetamol, codeine,
and caffeine in ratio of
500:8:30 mg,
respectively)
2 Tablets p.o. every 4 h
and Tramal 50 mg i.v. if
needed, 0e24 h
1 Lornoxicam reduced VASs and VASr at 4 h (P<0.05) and VASs at
24 h (P<0.05)
Lornoxicam increased time to 1st dose of paracetamol (P<0.05)
Lornoxicam reduced total dose of paracetamol (in Solpadeine)
0e12 h (P<0.05) and 0e24 h (P<0.05). None needed Tramadol
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Table 1 Continued
Reference (and
year)
No. of patients,
active/placebo
Study analgesics
Study arm
Placebo
Time of administration
Rescue analgesic, time of
administration
Duration of
follow-up
(days)
Analgesic outcome results (study drug vs placebo)
Mowafi and
colleagues31
(2011)
20/20 Lornoxicam 16 mg i.v.
Saline i.v.
30 min before induction
Diclofenac 50 mg p.r., 0.5
e24 h
1 Lornoxicam reduced VRSmax (P<0.001) and VRSr at 4 and 24 h
(P<0.001) and VRSs at 4 h (P<0.03), at 24 h NS
Lornoxicam reduced total dose and increased time to 1st dose
of diclofenac (P<0.001, P<0.001)
Xie and
colleagues32
(2012)
40/40 Parecoxib 40 mg i.v.
Saline i.v.
Intraop.,10 h
PACU: fentanyl 0.2 mg kg1
i.v. at 10 min intervals if
VRS5 (max 0.1 mg)
Ward: paracetamol 0.5 g
i.v. min. 6 h intervals
(max 2 g daily)
2 Parecoxib reduced VRSs at 2 h (P<0.001), and VRSs and VRSr at all
time points (P<0.001)
Parecoxib reduced proportion of patients that needed
paracetamol at ward (P<0.05), fentanyl at PACU NS
Ng and
colleagues33 (
2017)
40/40 Celecoxib 200 mg2 p.o. identical
placebo capsules p.o.
1e10 POD
PACU: morphine i.v. or
oxycodone 5 mg p.o.
every 6 h or when
needed
Home: oxycodone 5 mg
p.o., max 100 mg daily
10 Pain intensity (overall and daily) NS.
Total dose of oxycodone NS.
1st pain-free day and return to normal activities NS
Fields and
colleagues34
(1994)
29/29 Dexamethasone 8 mg i.v.
Saline i.v.
Intraop.
Elixir: paracetamol 250 mg
with codeine 7.5 mg in 5
ml p.o., 1e7 POD
7 Dexamethasone decreased pain intensity at 4 h (P<0.05), from 10
pm to 7th POD NS
Total and daily dose of paracetamolþcodeine elixir 1e10 POD
NS
Carr and
colleagues35
(1999)
15/14 Dexamethasone 20 mg i.v.
Saline i.v.
Intraop.
PACU: morphine i.v.,
pethidine i.v.
Ward: codeine and
paracetamol p.o.
Home: codeine p.o. every
4 h or if needed and
paracetamol, 1e10 POD
(doses unclear)
10 Pain intensity (>2 VAS change) NS. N of rescue analgesic dose in
PACU NS
Dexamethasone reduced total dose of pethidine/patient
(P¼0.03), but not total dose of morphine/patient. Proportion of
patients that needed rescue analgesics in PACU NS. Daily
doses of codeine and paracetamol 1e10 POD NS. Number of
days taken off from school or work and time until tolerating
normal diet NS
Stewart and
colleagues36
(2002)
48/52 Dexamethasone 8 mg i.v. at
induction, 2 mg p.o. at 10 pm, 2
mg p.o. twice daily for 1e4 POD,
then 2 mg daily for 5e8 POD
Saline i.v. and placebo tablets
p.o.
Intraop. and postop.
PACU: morphine 2 mg i.v.
Home: Co-codamol
(paracetamol 1g with
codeine 16 mg) 2 tablets
p.o. every 6 h or if
needed, 1e9 POD
9 Dexamethasone reduced pain intensity on all 1e9 POD, except
on 0 and 2nd POD, P<0.05. Dexamethasone decreased
proportion of patients that needed rescue analgesics (Co-
codamol >8 per day) (P¼0.024), and total dose of Co-codamol/
day on 2e7 POD (P<0.05). Total dose of morphine in PACU
unclear
Al-Shehri37
(2004)
15/15 Dexamethasone 6 mg i.v.
Saline i.v.
Intraop.,8, 16 h
None 10 Dexamethasone reduced VAS on 1 POD (P<0.05) and on 8 POD
(P<0.05). Total dose of analgesics NS. Patients in
dexamethasone group reduced their analgesic intake earlier
during 2nd week; at 7, 8, and 10 POD, P unclear
Rujirojindakul
and
colleagues38
(2008)
25/25 Dexamethasone 20 mg i.v.
Saline i.v.
Intraop.
PACU: fentanyl i.v. every 10
min if VRS>5 (dose
unclear)
Ward: paracetamol 10
mg kg1 p.o. every 6 h if
VRS>5 or morphine 3 mg
i.v. every 1 h if VRS>5
2 Dexamethasone reduced VRS at 4 h (P¼0.03), other times NS
Time to first rescue analgesic NS. Total dose of rescue
analgesics 0e48 h NS
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Table 1 Continued
Reference (and
year)
No. of patients,
active/placebo
Study analgesics
Study arm
Placebo
Time of administration
Rescue analgesic, time of
administration
Duration of
follow-up
(days)
Analgesic outcome results (study drug vs placebo)
Lachance and
colleagues39
(2008)
37/49 Dexamethasone 8 mg i.v. and 8
mg p.o. on 0 POD at home, 6 mg
twice on 1 POD, 4 mg twice on 2
POD; and 2 mg twice on 3 POD
Placebo in similar manner, type
unclear
Intraop. and postop.
Hospital: morphine 0.1 mg
kg1 i.v. (max 4 doses)
Home: hydromorphone 1
mg p.o. (max 20 mg), 0e4
POD
7 Dexamethasone reduced VASs on 2 POD (P¼0.047), other days NS
Hydromorphone consumption, NS
Vaiman and
colleagues40
(2011)
30/30 Dexamethasone 20 mg i.v.
Saline i.v.
20 h postop.
Not given 14e20 h (type or
route unclear)
1 Dexamethasone decreased VASs (postdrug vs predrug), P¼0.022,
while placebo did not. Dexamethasone also decreased
postdrug-VASs vs placebo (P<0.05)
Dexamethasone decreased muscle reactions and normalised
deglutition pattern (sEMG), while placebo did not (P<0.05)
Vaiman and
colleagues41
(2011)
30/30/30 Dexamethasone 20 mg i.v.
infusion
Oxycodone 2 mg h1 i.v.
infusion (14 mg)
Saline i.v. infusion
20 h postop.
Oxycodone and placebo:
infusion 16e23 h postop.
After the EMG test was
performed at 24 h (type
or route unclear)
1 Oxycodone and dexamethasone decreased VASs (postdrug vs
predrug) P<0.05, while placebo did not. Oxycodone decreased
postdrug-VASs vs placebo (P<0.05), dexamethasone did not.
Oxycodone decreased muscle reactions (sEMG), while
dexamethasone and placebo did not (P<0.05). Oxycodone and
dexamethasone, in case of oedema, decreased dysphagia
(P<0.05)
Thimmasettaiah
and
Chandrappa42
(2012)
25/25/25/25 Dexamethasone 0.5 mg kg1 i.v.
saline I.V. preop. (after inserting
i.v. cannula) vs intraop. vs
postop. (PACU)
placebo: intraop.
PACU: Tramadol mg kg1
i.v. if VAS>6
1 Dexamethasone decreased VAS at 6 h (P<0.05), at 12 h (P<0.001),
and at 24 h (P<0.001). Preop. and intraop. groups NS.
Dexamethasone reduced n of tramadol doses 0e24 h (P<0.05)
Khafagy and
Osman43
(2013)
43/31 Dexamethasone 0.3 mg kg1 i.v.
(max 8 mg)
Saline i.v.
Intraop.
Unclear 7 Dexamethasone reduced VAS on 0 POD and on 4e7 POD (P<0.05).
Dexamethasone reduced overall VAS during 0e7 POD
(P¼0.002). 1st liquid intake NS. 1st solid food intake:
dexamethasone earlier vs control group (P¼0.05)
Mikkelsen and
colleagues44
(2006)
22/27 Gabapentin 1200 mg p.o. 1 h
preop., 600 mg p.o. twice on
0 POD, 600 mg p.o. three times
on 1e5 POD
Placebo in similar manner, type
unclear
Preop. and postop.
Morphine 2.5 mg i.v., 0e4 h
Home: ketobemidone 2.5
mg p.o., 0e5 POD
5 VRSr and VASs 2e4 h and 1e5 POD, NS
Total dose of morphine 0e4 h NS
Gabapentin reduced total dose of ketobemidone 0e24 h, on
following days NS
Jeon and
colleagues45
(2009)
32/26 Gabapentin 600 mg p.o. on
previous evening and 600 mg
p.o. 1 h preop.
Similar capsule p.o.
Preop.
PCA fentanyl 20 mg bolus,
diclofenac 75 mg i.m., 0
e2 POD
9 Gabapentin reduced VASs at 2 and 4 h (P¼0.04, P¼0.04), on
following POD NS. VASr 0e7 POD NS
Gabapentin reduced total dose of PCA fentanyl (P¼0.002), and
total dose of diclofenac on 0e2 POD at hospital (P¼0.001).
Patient satisfaction NS
Abdelmageed
and
colleagues46
(2010)
30/30 Gabapentin 1200 mg p.o.
Placebo tablets, type unclear
2 h preop.
Pethidine 1 mg kg1 i.m.
every 6 h if VAS3 or if
needed
1 Gabapentin reduced VAS at all time points: 1, 3, 6, 12, 18, 24 h
(P<0.001). Gabapentin decreased worst VAS (P<0.001)
Gabapentin reduced total dose of pethidine 0e24 h (P<0.001)
and increased time to 1st dose of pethidine (P<0.001)
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Table 1 Continued
Reference (and
year)
No. of patients,
active/placebo
Study analgesics
Study arm
Placebo
Time of administration
Rescue analgesic, time of
administration
Duration of
follow-up
(days)
Analgesic outcome results (study drug vs placebo)
Mathiesen and
colleagues47
(2011)
43/45 Pregabalin 300 mg p.o.
Placebo, type unclear
1 h preop.
Morphine 2.5 mg i.v., 0e1 h
ketobemidone 2.5 mg
p.o., 0e24 h
1 Pregabalin reduced VASs at 2 and 4 h (P¼0.009, P<0.003)
Pregabalin also reduced VASsmean 2e24 h (P¼0.009) and VASr
at 4 h (P¼0.03). Pregabalin reduced total dose of ketobemidone
1e4 h (P¼0.003), 1e24 h NS. Total dose of morphine 0e1 h NS
Kawamata and
colleagues48
(1998)
12/12/12 Dextromethorphan 45 mg p.o.
Dextromethorphan 30 mg p.o.
Starch tablet p.o.
1 h preop.
Diclofenac 50 mg p.r., 0e6
POD
7 Dextromethorphan 45 mg decreased VASs and VASr on all 0e6
POD vs placebo (P<0.05). Dextromethorphan 30 mg decreased
VASs on 0 POD and VASr on 0, 1, and 6 POD (P<0.05).
Dextromethorphan 45 mg and 30 mg reduced total dose of
diclofenac/patient (P<0.05, P<0.05). Dextromethorphan
increased time to 1st dose of diclofenac (P<0.05)
Rafiei and
colleagues49
(2012)
20/20 Dextromethorphan 45 mg p.o.
Placebo tablet p.o.
1 h preop.
Pethidine 0.5 mg kg1 i.v. if
VAS3
1 Dextromethorphan increased pain-free time period (P¼0.002),
and decreased VASs 0e24 h (P¼0.047), VASr NS.
Dextromethorphan increased time to 1st dose of pethidine
(P¼0.005) and reduced total dose of pethidine/patient (P¼0.005)
Van Elstraete
and
colleagues50
(2004)
20/20 Ketamine 0.5 mg kg1 i.v. bolus
with ketamine 2 mg kg1 min1
infusion saline i.v. bolus with
i.v. infusion
Bolus at induction with infusion
until end of procedure
PACU: Morphine 3 mg i.v.
every 5min until VAS<30
Ward: morphine 10 mg
p.o. every 4 h until
VASs<30
Ketoprofen 100 mg p.o.
and paracetamol 500 mg
p.o., 0e24 h
1 Total dose of morphine/patient NS.
Time to 1st morphine dose at the ward NS.
VASr, VASs NS
Vaiman and
Krakovski51
(2012)
30/30 Oxycodone 2 mg h1 (14 mg) i.v.
infusion
Saline i.v. infusion
16e23 h postop.
Unclear 1 Oxycodone decreased VASs (postdrug vs predrug), P¼0.03, while
placebo did not. Oxycodone decreased postdrug VASs
(oxycodone vs placebo, P<0.05) and muscle reactions (sEMG),
P¼0.03
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Table 2 Reported pain intensity values during follow-up time. *pain intensity values not available, only need of rescue analgesics reported;:¼pain relief;-¼VAS/VRS/NRS,B¼VASs/
VRSs/NRSs;C¼VASr/VRSr/NRSr and VASs/VRSs/NRSs. NMDA, N-methyl-D-aspartate; NRS,; NRSr,; NRSs,; pod, postoperative day; VAS, visual analogue scale; VASr, VAS at rest; VASs,
VAS on swallowing; VRS, verbal rating scale; VRSr, VRS at rest; VRSs, VRS on swallowing; NRS, numeric rating scale; NRSr, NRS at rest; NRSs, NRS at swallowing
Study (and year) 1 h 2 h 4 h 12 h 24 h 2 pod 3 pod 4 pod 5 pod 6 pod 7 pod 8 pod 9 pod 10 pod
Paracetamol
Atef and Fawaz23 (2008) C C C C
Salonen and colleagues24 (2009) C C C
NSAIDs
Parker and colleagues25 (1986), ibuprofen, acetylsalicylic acid : : : : : : : :
Rorarius and colleagues26 (1993), indomethacin, diclofenac * *
Tarkkila and Saarnivaara27 (1999), ketoprofen C C
Salonen and colleagues28 (2001), ketoprofen C C C C
Naesh and colleagues29 (2005), rofecoxib - - -
Ismail and Mowafi30 (2010), lornoxicam C C C C C
Mowafi and colleagues31 (2011), lornoxicam C C C C C
Xie and colleagues32 (2012), parecoxib C C C C C
Ng and colleagues33 (2017), celecoxib C C C C C C C C
Dexamethasone
Fields and colleagues34 (1994) - - - - - - - - -
Carr and colleagues35 (1999) B B B B B B B B B B
Stewart and colleagues36 (2002) B B B B B B B B B B
Al-Shehri37 (2004) - - - - - - - - -
Rujirojindakul and colleagues38 (2008) - - - -
Lachance and colleagues39 (2008) B B B B B B B
Vaiman and colleagues40 (2011) B
Vaiman and colleagues41 (2011) B
Thimmasettaiah and Chandrappa42 (2012) - -
Khafagy and Osman43 (2013) - - - - - -
Gabapentinoids
Mikkelsen and colleagues44 (2006), gabapentin C C C C C C
Jeon and colleagues45 (2009), gabapentin C C C C C C C C C C C C C
Abdelmageed and colleagues46 (2010), gabapentin - - -
Mathiesen and colleagues47 (2011), pregabalin C C C
NMDA antagonists
Kawamata and colleagues48 (1998), dextromethorphan C C C C C C
Rafiei and colleagues49 (2012), dextromethorphan C
Van Elstraete and colleagues50 (2004), ketamine C C C C C
Opioids
Vaiman and Krakovski51 (2012), oxycodone B
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Fig 2. Risk of bias graph. Review authors’ judgments about each
risk of bias item presented as percentages across all included
studies.
e406 - Tolska et al.In other NSAID studies, the reporting of pain intensities
was unsuitable for meta-analysis (pain relief,25 median values
instead of mean29e33) and the results are presented descrip-
tively. In a study25 with oral ibuprofen 600 mg, acetylsalicylic
acid 600 mg, or placebo 0e4 times daily for 6 postoperative
days in patients with moderate to severe post-tonsillectomy
pain, pain relief within 24 h after initial treatment was faster
with ibuprofen compared with placebo. Acetylsalicylic acid
did not have any effect on pain outcomes. In a study26 of
diclofenac 75 mg i.v. and indomethacin 50 mg i.v. intra-
operatively, indomethacin reduced the need for opioids at the
PACU, while diclofenac had no effect.
Cyclooxygenase-2 selective NSAIDs, lornoxicam 16 mg i.v.
before operation in two studies30,31 and parecoxib 40 mg i.v.
intraoperatively and after operation32 reduced pain and theFig 3. Pain intensities during 1e9 postoperative days (POD). (a)
Placebo groups; (b) study groups.need for rescue analgesia within 24 h. Oral rofecoxib 50 mg
before operation decreased the incidence of pain (VAS>5) and
the need for opioids within the first 8 h.29 Celecoxib 200 mg
twice daily for 1e10 postoperative days with additional para-
cetamol 1 g four times daily did not reduce pain or need for
opioids.33
The majority of patients given NSAIDs (74%) or placebo
(85%) needed rescue analgesia within 24 h after the operation
(relative risk [RR] 0.91 [95% CI 0.79e1.05], P¼0.21).27,28,30e32 Six
studies27,28,30e33 reported incidence of PTH; none found an
increased risk.Randomised studies comparing dexamethasone with
placebo
Ten studies34e43 including 590 patients are summarised in
Table 1 (Supplementary Appendix A1). Pooled estimates
demonstrated that single-dose dexamethasone of 8 mg to
0.5 mg kg1 decreased pain intensity equivalent to 23% at 4
h (1.40 [95% CI 1.64 to 1.16], P<0.001, I2¼0%) but no
longer at 24 h (P¼0.05) (Fig. 4, Supplementary Appendix S4).
When the only multiple-dose study37 suitable for meta-
analysis was included, a significant 17% reduction at 24 h
was observed, although with a high heterogeneity (I2¼93%).
In two studies with high single doses of dexamethasone (20
mg35 and 0.5 mg kg142), the need for rescue opioids
decreased in the PACU. Reduction of pain intensity lasted
beyond the first postoperative day in all multiple-dose
studies and in one single-dose study.36,37,39,43 The total
dose of rescue analgesic (combination of paracetamol 500
mg and codeine 16 mg) was reduced over 2e7 postoperative
days in a study on dexamethasone for 8 postoperative
days.36
Pooled estimates demonstrated that dexamethasone was
associated with less PONV during 24e48 h after operation (RR
0.41 [95% CI 0.29e0.59], P<0.001, I2¼0%)35,36,38,42 without in-
crease in risk for PTH (RR 0.76 [95% CI 0.37e1.56], P¼0.46,
I2¼0%)35,36,38,42 (four studies reported risk for PTH).Randomised studies comparing gabapentinoids with
placebo
Four studies including 255 patients (three gabapentin44e46 and
one pregabalin47) are summarised in Table 1 (and
Supplementary Appendix S1). Pooled estimates demonstrated
that gabapentinoids decreased pain intensity equivalent to
30% at 4 h (1.58 [95% CI 2.28 to 0.88], P<0.001, I2¼0%) and
equivalent to 13% at 24 h (1.03 [95% CI 1.30 to 0.77],
P<0.001, I2¼0%) (Fig. 4, Supplementary Appendix S5). Gaba-
pentin 300e2400 mg on the day of operation reduced the need
for rescue analgesics (opioids or diclofenac) within 24 h.44e46
Pregabalin 300 mg reduced the need for opioids within 4 h.47
In one study44 with high and multiple doses of gabapentin,
adverse events were common and outweighed beneficial ef-
fects. Gabapentin decreased postoperative vomiting in pooled
analysis estimation, most likely because of the decreased need
for rescue opioids (RR 0.55 [95% CI 0.32e0.95], P¼0.03, I2¼2%).Randomised studies comparing NMDA receptor
antagonists with placebo
Three studies (116 patients) on NMDA receptor antagonists
(two dextrometorphan48,49 and one ketamine50) are summar-
ised in Table 1 (Supplementary Appendix S1). Ketamine50 and
Fig 4. Forest plot showing the effect of perioperatively administered analgesics and dexamethasone on pain intensity at 24 h. Pain in-
tensity values (scale 0e10) with confidence intervals (CI). Data evaluated using a random effects model.
Systematic review on analgesics and dexamethasone - e407dextromethorphan studies48,49 were too heterogeneous to be
combined in pooled analysis. Dextromethorphan 45 mg
reduced VASs and the total dose of rescue analgesics within 24
h, and prolonged time to first request of rescue analgesics in
both studies.48,49 In the study of Kawamata and colleagues,48
dextromethorphan reduced pain intensity over the follow-up
period of 6 postoperative days.
Ketamine as an intraoperative bolus and infusion failed to
reduce pain intensity and total dose of opioids, and did not
prolong the time to first analgesic requests over a follow-up
period of 24 h.50 Ketamine did not increase the incidence of
adverse events; nausea and sedation scores were similar be-
tween the study groups and none experienced hallucinations
or nightmares.Randomised studies comparing opioids with placebo
One study on oxycodone51 including 60 patients is summar-
ised in Table 1 (and Supplementary Appendix S1). I.V.oxycodone 2 mg h1 decreased pain intensity at 24 h after
operation. Data on rescue analgesics or adverse events were
not reported.Discussion
Summary of evidence
The main finding of this review was the scarcity of data and
short duration of follow-up in studies that investigated anal-
gesics for post-tonsillectomy pain. This finding is clinically
relevant considering the number of tonsillectomies performed
yearly and the intensity of pain after the procedure. I.V.
paracetamol reduced pain intensity at 3e4 h and the need for
opioids 24 h after surgery. Ketoprofen at varying doses (100
mg or 0.5 mg kg1 i.v.) failed to decrease pain intensity within
24 h. However, both studies reported a reduced need for opi-
oids within 24 h. In other NSAID studies, pooled analysis was
not possible because of the large heterogeneity. In individual
studies, NSAIDs administered on the day of operation reduced
e408 - Tolska et al.pain intensity, the need for rescue analgesics, or both within
24 h. Celecoxib on postoperative days 1e10 had no effect on
pain intensity or the need for opioids. In all NSAID studies, the
majority of patients needed rescue analgesics, thus indicating
that NSAIDs alone do not provide adequate analgesia for
tonsillectomy patients.
Dexamethasone as a single intraoperative dose reduced
pain within 4 h. When administered in multiple doses, the
effect lasted beyond the first postoperative day. Gabapenti-
noids and dextromethorphan decreased pain intensity and
need of rescue analgesia within 24 hours. Ketamine failed to
show any effect at the studied dose.
Because of the high post-tonsillectomy pain intensity, the
analgesic effect did not reach clinical meaningfulness when
any of the analgesics or dexamethasonewas used alone. PONV
was reduced by dexamethasone and gabapentinoids over
24e48 h after operation because of antiemetic and opioid-
sparing effects. The incidence of PTH was reported in para-
cetamol, NSAID and dexamethasone studies; no increase in
the risk for PTH was found. Serious adverse events were not
reported.Limitations
A systematic review and meta-analysis combine data to esti-
mate treatment effects more precisely than is possible in
single studies. However, the accuracy of results of systematic
reviews depends on the availability and quality of the data
available. A thorough search was performed, and all relevant
studies were likely included in the study. Only studies in En-
glish were included, which could limit the accuracy of results;
however, no evidence of a systematic bias from the use of
English language restriction in systematic review-basedmeta-
analyses in conventional medicine has been found.20 Funnel
plots of the results were drawn and examined in the review
group and did not show any apparent publication bias among
studies.
Studies were clinically heterogeneous with varying timing
of study medications, use of rescue and additional analgesics,
and duration of follow-up. Therefore, combining results in
meta-analysis was possible only in selected studies and only
for pain intensity. Although therewere sub-optimally only two
studies in some analgesic groups, we conducted a meta-
analysis also for them to allow rough comparison between
groups.
In the present study, 12 out of 29 included trials failed to
report the primary outcome thus presenting a risk for bias.
The main limitation was the short study and follow-up
time, especially in the NSAID studies. From the patient point
of view, adequate pain management at home is important. At
hospital, pain can be easily treated with opioids, but problems
arise after discharge when strong opioids are not available.
There are minimal data on optimal analgesics for post-
tonsillectomy pain at home.
All studies did not report pain intensities at rest and on
swallowing, thus decreasing the accuracy of the results. Pain
on movement (swallowing) should be reported, as it is a major
determinant of how well patients can drink and eat at home
during recovery.Comparison with results of previous studies
In a Cochrane review (that included the two studies also
included in this review), a single dose of either paracetamol orpropacetamol i.v. was found to provide approximately 4 h of
effective analgesia for about 36% of patients with acute post-
operative pain.8,23,24 This is consistent with our findings that
paracetamol 1e2 g i.v. intraoperatively decreased pain in-
tensity at 3e4 h. A reduced need for opioids within 24 h was
reported in both studies with a cumulative dose of paraceta-
mol 4 g i.v.23 and a single dose of paracetamol 2 g i.v.24
NSAIDs are widely used for postoperative pain and are
effective for various types of surgical pain.52,53 We found no
previous reviews of NSAIDs for post-tonsillectomy pain in
adults. Consistent with previous reports, NSAIDs reduced pain
intensity or need for rescue analgesics in most studies.
A review on perioperative single-dose dexamethasone for
postoperative pain14 (that included one study35 also included
here) reported reduced pain intensity at 4 and 24 h and opioid
consumption at a high dose of dexamethasone (more than 0.1
mg kg1). A review on dexamethasone and post-tonsillectomy
morbidity15 (that included five studies34e37,39 also included
here) reported reduced pain intensity on the first post-
operative day with high-dose (>10 mg) steroids (P<0.001). Our
results in the present review are comparable. We did not
observe an increased risk for PTH associated with the use of
dexamethasone. Two recent studies (a register study and a
systematic review) indicate an increased risk for reoperation
as a result of PTH in children, but not in adults.54,55
Previous reviews on perioperative gabapentinoids have
found a reduction of postoperative pain, opioid consumption,
and opioid-related adverse effects.5,18 A recent systematic re-
view that analysed the benefit of pregabalin for acute pain
reported a minimal opioid-sparing effect in studies with low
overall risk of bias; this review included two tonsillectomy
studies, of which one was also included in our analysis.47 We
found similar analgesic effects in our study; gabapentinoids
reduced pain at 4 and 24 h after operation in pooled analysis.
However, regarding observed pain reduction at 24 h, one
study46 with an unclear overall risk for bias was responsible
for the majority of the effect (60% weight). When an analysis
that excluded this study was performed, there was no signif-
icant reduction in pain intensity. Gabapentin 300e1200 mg
before operation reduced the need for opioids within 4 and 24
h44e46 and pregabalin 300 mg before operation reduced this
need within 4 h.47 Previous results on adverse effects associ-
ated with gabapentinoids compared with placebo are con-
flicting.5,18 In the present study, the risk of adverse effects was
not increased except in one high-dose study, where dizziness,
vomiting, and gait disturbance were more frequent in the
study group.44
Dextromethorphan is an NMDA receptor antagonist and is
a widely used antitussive medication. Dextromethorphan has
been shown to potentiate the antinociceptive effects of opiates
and prevent pain sensitivity and opioid tolerance without
significant side-effects.56,57 A review of 28 studies on periop-
erative dextromethorphan (including one study48 also
included here) revealed a reduced need for opioids and
considered perioperative dextromethorphan as a safe adju-
vant agent to opioid analgesia.57 In our study, dextromethor-
phan 45 mg before operation decreased pain intensity over 24
h and total dose and time to first rescue analgesic in both
studies.48,49 Ketamine is a well-known NMDA receptor antag-
onist and when used in subanaesthetic doses can reduce
opioid requirements, pain sensitivity, or both in acute post-
operative pain with mild or absent adverse effects (Cochrane
review 2005).58 In a systematic review (2014) in paediatric
tonsillectomies, i.v. ketamine before operation showed an
Systematic review on analgesics and dexamethasone - e409opioid-sparing effect and a reduction of pain intensity and
time to resumption of liquid diet.59 Adverse effects such as
nausea and vomiting, sedation, bad dreams, sleep pattern
change, or hallucinations were absent. In the present review,
the only ketamine study included failed to be effective in
studied doses.
We did not find reviews on opioids for post-tonsillectomy
pain. We included only one opioid study in which post-
operative oxycodone infusion decreased pain intensity as
expected.Conclusions and clinical implications
This study confirmed the beneficial analgesic effects of para-
cetamol, NSAIDs, dexamethasone, gabapentinoids, and dex-
tromethorphan for post-tonsillectomy pain on the day of
operation. Dexamethasone in multiple doses had an analgesic
effect that exceeded 24 h. However, the use of steroids with
high total doses or continued after the day of operation must
be done with caution considering both the risks and benefits.
Based on our results, gabapentin, pregabalin, and possibly
dextromethorphan could be useful at moderate doses as ad-
juvants to other analgesics. Ketamine in subanaesthetic doses
is effective in various types of surgeries in decreasing the need
for opioids and pain sensitivity. Although ketamine was not
effective in the one included study in our analysis, it may have
efficacy for post-tonsillectomy pain; this should be studied in
further trials.
The short follow-up times and clinical heterogeneity of
studies limit the usefulness of the results, which should be
interpreted with caution.
Single analgesics or dexamethasone alone do not provide a
clinically meaningful analgesic effect for the treatment of
post-tonsillectomy pain. Multimodal analgesia is thus
required. Further studies are needed to identify the best
possible combinations. Pain on swallowing should be used as a
primary analgesic outcome and a follow-up time of 1e2
postoperative weeks is recommended.Authors’ contributions
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